期刊文献+

噻唑橙光化学法对红细胞中病毒及细菌灭活作用的研究 被引量:2

Inactivation of virus and bacteria in red blood cell suspension by Thiazole orange photo-chemistry
下载PDF
导出
摘要 目的探讨噻唑橙(TO)光化学法对红细胞中病毒及细菌灭活效果。方法以伪狂犬病毒(PRV)和辛德毕斯(Sindbis)病毒为指示病毒,分别加入红细胞比积为20%的红细胞悬液中,TO孵育1 h后做476 nm光照射处理;研究病毒灭活动力学特征;做TO浓度(C)、光照强度(I)、光照时间(T)三因素三水平正交试验确定最优灭活条件;最优条件下检测裸照、密闭血袋中、密闭血袋充氧后的病毒灭活效果;最优条件下检测血液污染常见细菌小肠结肠炎耶尔森氏菌、金黄色葡萄球菌及表皮葡萄球菌灭活效果。结果病毒灭活动力学研究显示:在60μmol/LTO、1.06E-01 w·m-2·nm-1光强条件下,照射5 min可将大部分PRV和Sindbis病毒灭活,20 min灭活作用达峰值,分别为5.88和5.12 LogTCID50;正交试验显示:裸照时PRV及Sindbis病毒灭活最优条件均为I=1.33E-01 w·m-2·nm-1,T=20 min,C=80μmol/L;在此条件下,可灭活红细胞中PRV≥6.13LogTCID50(裸照,n=4)、(4.75±0.62)LogTCID50(密闭血袋,n=4)、(6.06±0.16)LogTCID50(密闭血袋充氧,n=4);可灭活红细胞中Sindbis病毒(5.41±0.12)LogTCID50(裸照,n=4)、(3.72±0.77)LogTCID50(密闭血袋,n=4)、(5.76±0.25)LogTCID50(密闭血袋充氧,n=4)。在此条件下细菌灭活效果:小肠结肠炎耶尔森氏菌(5.91±0.13)Log10、金黄色葡萄球菌>6.8Log10、表皮葡萄球菌>6.0 Log10。结论 TO光化学法可有效灭活红细胞中病毒,有氧情况下(裸照或充氧)病毒灭活效果好于密闭无氧。TO光化学法可有效灭活红细胞中细菌。 Objective To evaluate the inactivation effect of thiazole orange(TO) photo-chemistry on virus and bacteria in red blood cell(RBC) suspension.Methods Pseudorabies virus(PRV) and Sindbis virus were used as indicator virus,and virus infected samples were prepared by adding PRV or Sindbis virus to RBC suspension(RBC).Incubated the samples with TO 1 h and exposed them to 476 nm light.Viral inactivation kinetics was first studied.Then the optimal condition for virus inactivation was determined by orthogonal test,in which 3 factors were studied namely TO concentration(C),light intensity(I),irradiation time(T).Finally,the inactivation effects of TO on virus were tested on naked samples,samples in bags,and oxygenated samples in bags under the optimal inactivation condition.Moreover,the inactivation effects of TO on bacteria were also tested,including Staphylococcus aureus,Staphylococcus epidermidis,Yersinia enterocolitica.Results Samples with 60 μmol/L TO exposed to 1.06E-01 w·m-2·nm-1 light for 5 min resulted in inactivation of most PRV and Sindbis virus in RBC suspension,and for 20 min,5.88 Log TCID50 PRV and 5.12 LogTCID50 Sindbis virus were inactivated.The optimal inactivation condition for both PRV and Sindbis virus was,I=1.33E-01w·m-2·nm-1,T=20 min,C=80 μmol/L.Under this condition,≥6.13 Log TCID50(naked samples,n=4),(4.75±0.62)LogTCID50(samples in bags,n=4) and(6.06±0.16) LogTCID50(oxygenated samples in bags,n=4) PRV were inactivated;(5.41±0.12)LogTCID50(naked samples,n=4),(3.72±0.77)LogTCID50(samples in bags,n=4) and(5.76±0.25)LogTCID50(oxygenated samples in bags,n=4) Sindbis virus were inactivated,respectively.Moreover,under this optimal condition,(5.91±0.13)Log10 Yersinia enterocolitica,〉6.8 Log10 Staphylococcus aureus,and 〉6.0 Log10 Staphylococcus epidermidis were inactivated.Conclusion TO photo-chemistry is an effective method for virus inactivation in RBC,and its effect is enhanced under oxygen condition compared with low oxygen closed bag;TO photo-chemistry is also an effective method for bacteria inactivation in RBC.
出处 《中国输血杂志》 CAS CSCD 北大核心 2012年第5期410-414,共5页 Chinese Journal of Blood Transfusion
基金 北京市自然科学基金(7082049)
关键词 噻唑橙 光化学法 红细胞 病毒灭活 细菌灭活 伪狂犬病毒 辛德毕斯病毒 TO Photo-chemistry RBC suspension ( RBC ) Virus inactivation Bacteria inactivation Pseudorabies vires Sindbis virus
  • 相关文献

参考文献12

  • 1Dodd RY. Current risk for transfusion transmitted infections. Curr Opin Hematol,2007,14(6) : 671-676.
  • 2Lindholm PF,Annen K, Ramsey G. Approaches to minimize infec- tion risk in blood banking and transfusion practice. Infect Disord Drug Targets,2011,11 ( 1 ) :45-56.
  • 3PeUetier JP, Transue S, Snyder EL. Pathogen inactivation tech- niques. Best Pract Res Clin Haenatol ,2006 ,19 (1) : 205-242.
  • 4Soheim BG. Pathogen reduction of blood component. Tansfus Apher Sci,2008,39 (1) : 75-82.
  • 5Wagner SJ. Developing pathogen reduction technologies for RBC suspensions. Vox Sang,2011,100 ( 1 ) : 112-121.
  • 6Carlsson C, Jonsson M, Akerman B. Double bands in lectrophore- sisophoresis caused by bis- intercalating dyes. Nucleic Acids Res, 1995,23(13) : 2413-2420.
  • 7Skripehenko A, Wagner SJ,Thompson-Montgomery D, et al. Thiazole orange,a DNA- binding photosensitizer with flexible structure, can inactivate pathogens in red blood cell suspensions while maintaining red cell storage properties. Transfusion,2006,46(2) : 213-219.
  • 8王卓妍,任芙蓉,周锡鹏,许金波,吕秋霜,龚晓燕.辛德比斯病毒和伪狂犬病毒制备方法的优化[J].中国输血杂志,2008,21(11):852-854. 被引量:3
  • 9中华人民共和国卫生部.消毒技术规范.北京:人民卫生出版社,2002;156-165.
  • 10国家药品监督管理局.血液制品去除/灭活病毒技术方法及验证指导原则.2002-05-09.

二级参考文献27

  • 1钱开诚,陆萍,凌冰,黄宇闻,高峰,张钦辉.亚甲兰光化学法红细胞病毒灭活的初步探讨[J].临床输血与检验,2001,3(3):2-5. 被引量:7
  • 2江朝富,张晓敏,聂咏梅,汪传喜,付涌水,曹开源.光化学法病毒灭活的模型病毒培养与滴定方法的建立[J].广州医药,2006,37(1):23-24. 被引量:2
  • 3国家药品监督管理局.血液制品去除/灭活病毒技术方法及验证指导原则[S].国药监注[2002]160号.
  • 4陈世明.药物毒理学方法[M]//张均田.现代药理实验方法.北京:北京医科大学中国协和医科大学联合出版,1998,18IO-1827.
  • 5国家药品监督管理局.血液制品去除/灭活病毒技术方法及验证指导原则.2002.
  • 6Schreiber GB,Bush MP,Kleinman SH,et al.The risk of transfu-sion transmitted viral infection.The retrovirus epidemiology donorsstudy.N Engl J Med,1996,334(26):1685-1690.
  • 7Siekmeier R,Bierlich A,Jaross W.Determination of reticulocytes:three methods compared.Clin Chem Lab Med,2000,38(3):245-249.
  • 8Skripchenko A,Wagner SJ,Thompson-Montgomery D,et al.Thia-zole orange,a DNA-binding photosensitizer with flexible structure,can inactivate pathogens in red blood cell suspensions while main-taining red cell storage properties.Transfusion,2006,46(2):213-219.
  • 9S.J.Wagner.Developing pathogen reduction technologies for RBCsuspensions.Vox Sang,2011,100(1):112-121.
  • 10Kleinman SH, Lelie N, Busch MP. Infectivity of human immunode- ficiency virus-1 ,hepatitis C virus,and hepatitis B virus and risk of transmission by transfusion. Transfusion, 2009,49 ( 11 ) : 2454- 2489.

共引文献26

同被引文献33

  • 1Busch MP, Young MJ,Samson SM, et al. Risk of human immunode-ficiency virus (HIV) transmission by blood transfusions before the implementation of HIV-1 antibody screening. The Transfusion Safe- ty Study Group. Transfusion, 1991,31 ( 1 ) :4-11.
  • 2AuBuehon JP and Prowse CV. Pathogen Inactivation: the penulti- mate paradigm shift. Bethesda :AABB Press,,2010 : X VM Stassino- poulos A, Mababangloob RS, Dupuis KW, et al. Bacterial inactiva- tion in leukoreduced PRBC treated with HELINX. Transfusion, 2000.40(Suool) :38S ( abstract S139-0401 J.
  • 3Corash L. Inactivation of viruses, bacteria, protozoa and leukoeytes in platelet and red cell concentrates. Vox Sang,2001,78($2) :205.
  • 4Wagner SJ. Developing pathogen reduction technologies for RBC suspensions. Vox Sang,2011,100 ( 1 ) : 112-121 (review).
  • 5Rios JA, Hambleton J, Viele M, et al. Viability of red cells prepared with S-303 pathogen inactivation treatment. Transfusion, 2006,46 (10) :1778-1786.
  • 6Hensehler R , Seifried E , Mufti N. Development of the S-303 Pathogen Inactivation Technology for Red Blood Cell Concentrates. Transfus Med Hemother,2011,38 ( 1 ) :33-42.
  • 7Cancelas, LJ Dumont L.I, Rugg Net al. Stored red blood cell viability is maintained after treatment with a second-generation S-303 patho- gen inactivation process. Transfusion ,2011,51 ( 11 ) :2367-2376.
  • 8Lazo A, TasseUo J, JayaramaV, et al. Broad-spectrum virus reduc- tion in red cell concentrates using INACTINE trade mark PEN110 chemistry. Vox Sang,2002,83(4) : 313-323.
  • 9Zavizion B, Serebryanik D, Chapman J, et al. Inactivation of Gram- negative and Gram-positive bacteria in red cell concentrates using INACTINE PEN110 chemistry. Vox Sang,2004,87 (3) : 143-149.
  • 10Zavizion B, Pereira M, Jorge MM, et al. Inactivation of protozoan parasites in red blood cells using INACTINE PENll0 chemistry. Transfusion,2004,44(5 ) :731-738.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部